Floatz logo

271 assets in Renal Cell Carcinoma

Therapeutic assets addressing Renal Cell Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Abexinostat
Renal Cell Carcinoma
Xynomic Pharmaceuticals, Inc.P3CCC (52)
Adavosertib
Renal Cell Carcinoma
National Cancer Institute (NCI)P2CCC (52)
Cik Cells
Renal Cell Carcinoma
Institute of Biophysics and Cell Engineering of National Academy of Sciences of BelarusP2CCC (52)
Hydroxychloroquine
Renal Cell Carcinoma
Leonard ApplemanP1/2CCC (52)
Ivonescimab
Renal Cell Carcinoma
City of Hope Medical CenterP2CCC (52)
Piflufolastat
Renal Cell Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsP2CCC (52)
Relatlimab
Renal Cell Carcinoma
The Netherlands Cancer InstituteP2CCC (52)
Zimberelimab
Renal Cell Carcinoma
Dana-Farber Cancer InstituteP2CCC (52)
Entinostat
Renal Cell Carcinoma
Roberto PiliP2CCC (51)
Ketorolac
Renal Cell Carcinoma
University of MiamiP2CCC (51)
Pyruvate
Renal Cell Carcinoma
Zhen Wang, MDP2CCC (51)
Abemaciclib
Renal Cell Carcinoma
Memorial Sloan Kettering Cancer CenterP1/2CCC (50)
Alectinib
Renal Cell Carcinoma
Cancer Research UKP2/3CCC (50)
Elraglusib
Renal Cell Carcinoma
Actuate Therapeutics Inc.P2CCC (50)
Eribulin
Renal Cell Carcinoma
Oliver JonasP1/2CCC (50)
1H-ISOINDOL-1-ONE, 7-((6-((DIMETHYLAMINO)METHYL)-5-((3S)-TETRAHYDRO-3-FURANYL)-2-PYRIDINYL)AMINO)-4-(7-FLUOROIMIDAZO(1,2-A)PYRIDIN-3-YL)-2,3-DIHYDRO-
Renal Cell Carcinoma
Nimbus Saturn, Inc.P1/2CCC (48)
Casdatifan
Renal Cell Carcinoma
Dana-Farber Cancer InstituteP2CCC (48)
Catequentinib
Renal Cell Carcinoma
Fujian Cancer HospitalP2CCC (48)
Dentalfluoro
Renal Cell Carcinoma
National Cancer Institute (NCI)P2CCC (48)
Entrectinib
Renal Cell Carcinoma
Hoffmann-La RocheP2CCC (48)
Humanized Monoclonal Anti-Fgfr1 Antibody Om-Rca-01
Renal Cell Carcinoma
Kidney Cancer Research BureauP1/2CCC (48)
Intismeran Autogene
Renal Cell Carcinoma
Merck Sharp & Dohme LLCP2CCC (48)
Pd-L1 T-Hank
Renal Cell Carcinoma
ImmunityBio, Inc.P2CCC (48)
Pucotenlimab
Renal Cell Carcinoma
Sun Yat-sen UniversityP2CCC (48)
Pumitamig
Renal Cell Carcinoma
Bristol-Myers SquibbP1/2CCC (48)
Sargramostim
Renal Cell Carcinoma
Mayo ClinicP1/2CCC (48)
Tobemstomig
Renal Cell Carcinoma
Hoffmann-La RocheP2CCC (48)
Zirconium Zr 89 Crefmirlimab Berdoxam
Renal Cell Carcinoma
ImaginAb, Inc.P2CCC (48)
Anti-Clever-1 Monoclonal Antibody Fp-1305
Renal Cell Carcinoma
Faron Pharmaceuticals LtdP1/2CC (47)
Anti-Hcd70 Car Transduced Pbl
Renal Cell Carcinoma
National Cancer Institute (NCI)P1/2CC (47)
Bemarituzumab
Renal Cell Carcinoma
Fujian Cancer HospitalP2CC (47)
Bicalutamide
Renal Cell Carcinoma
State University of New York at BuffaloP1/2CC (47)
Bms-936558-01
Renal Cell Carcinoma
Bristol-Myers SquibbP1/2CC (47)
Favezelimab
Renal Cell Carcinoma
Merck Sharp & Dohme LLCP1/2CC (47)
Immunoglobulin G1 [De-C-Terminal-Lysine], Anti-(Human Cc Chemokine Receptor Ccr8) (Human-Mus Musculus Monoclonal Bms-986340 ?1-Chain), Disulfide With Human-Mus Musculus Monoclonal Bms-986340 ?-Chain, Dimer
Renal Cell Carcinoma
Bristol-Myers SquibbP1/2CC (47)
mk-4830
Renal Cell Carcinoma
Merck Sharp & Dohme LLCP1/2CC (47)
Modi-1 Moditope
Renal Cell Carcinoma
Scancell LtdP1/2CC (47)
pf-08634404
Renal Cell Carcinoma
PfizerP1/2CC (47)
tt-10
Renal Cell Carcinoma
Portage BiotechP1/2CC (47)
tt-4
Renal Cell Carcinoma
Portage BiotechP1/2CC (47)
Vibostolimab
Renal Cell Carcinoma
Merck Sharp & Dohme LLCP1/2CC (47)
64cu-grip b
Renal Cell Carcinoma
Rahul AggarwalP1/2CC (45)
gi-102
Renal Cell Carcinoma
GI Innovation, Inc.P1/2CC (45)
gi-108
Renal Cell Carcinoma
GI Innovation, Inc.P1/2CC (45)
Gotistobart
Renal Cell Carcinoma
OncoC4, Inc.P1/2CC (45)
Lutetium (<Sup>177</Sup>Lu) Zadavotide Guraxetan
Renal Cell Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsP1/2CC (45)
mdx2001
Renal Cell Carcinoma
ModeX Therapeutics, An OPKO Health CompanyP1/2CC (45)
SL-28
Renal Cell Carcinoma
Second Life TherapeuticsP1/2CC (45)
st-1898 tablets
Renal Cell Carcinoma
Beijing Scitech-Mq Pharmaceuticals LimitedP1/2CC (45)
Vmd-102
Renal Cell Carcinoma
VM Discovery, Inc.P1/2CC (45)
Showing 101 to 150 of 271 assets
PreviousPage 3 of 6Next